Romulus (ROM) is a software add-on for mechanical ventilators — non-invasive, data-driven, built on six years of biomedical engineering research — giving physicians earlier, better-informed treatment decisions.
Andy Keymolen and Antoine Marchal each dedicated their PhD in biomedical engineering to improving invasive mechanical ventilation, and have worked together on this problem for six years.
Mathematical models, machine learning, software. Leads operations & quality.
Fund-raising, clinical trials, regulatory affairs, IP, and physician networking. Led the research.
Every milestone we've hit, and the ones we're working toward next — scroll to move forward in time.
Both founders dedicated their PhD in biomedical engineering to improving invasive mechanical ventilation — the research foundation Romulus is built on.
Run together with Demcon on 21 ICU patients — physicians are confident the approach can reduce mechanical-ventilator weaning failures by 33%.
Awarded on the strength of the pilot data — independent validation from grant reviewers, not just our own assessment.
Our proof-of-concept partner is now under NDA for further integration work toward a full product integration.
Halle, UZ Leuven, Brugmann, and UZ Brussel have given written expressions of interest in evaluating Romulus.
Our pivotal trial, integrating a second signal (sEMG / diaphragm activity) alongside our existing pressure-based measurement.
Regulatory and quality-management-system work runs in parallel with the pivotal trial, toward OEM-level MDR certification.
Targeting signed sales contracts and a first field implementation with our early ICU partners.
A second clinical trial validating patient-outcome benefit across our combined pressure + sEMG measurement.
Our respiratory-mechanics feature reaches its first ICU patients in daily clinical use.
Building on preliminary CT2 data, extending Romulus to diaphragm-activity monitoring.
A cloud-based, multi-signal platform, extending from the ICU to home respiratory monitoring.